Louis F. Fabre
Louis F. Fabre publishes mostly in Psychiatry and Mental health, Pharmacology and Endocrinology, Diabetes and Metabolism, on topics such as Treatment of Major Depression, Schizophrenia research and treatment and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes.
- World rank
- #1,880,267 of 7,710,434 ranked researchers
- Rank in United States
- #575,078 of 1,627,098
- Works
- 64
- Citations
- 2.1k
- Citations per work
- 33.6
What does Louis F. Fabre research?
Louis F. Fabre's work is mostly in Medicine (39%), Psychology (14%), Neuroscience (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2741.7%
- Health Sciences2539.3%
- Medicine2539.3%
- Social Sciences913.5%
- Psychology913.5%
- Life Sciences45.5%
- Neuroscience45.5%
- 1Psychiatry and Mental health16% of their works
- 2Pharmacology15% of their works
- 3Endocrinology, Diabetes and Metabolism9% of their works
- 4Experimental and Cognitive Psychology7% of their works
- 5Clinical Psychology6% of their works
- 6Cellular and Molecular Neuroscience6% of their works
Research topics
- Treatment of Major Depression
- Schizophrenia research and treatment
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Neurotransmitter Receptor Influence on Behavior
- Hormonal Regulation and Hypertension
- Hormonal and reproductive studies
- Sexual function and dysfunction studies
- Pharmacogenetics and Drug Metabolism
Which keywords describe Louis F. Fabre's research?
The keywords of their largest research topics: Metabolic Syndrome, Antidepressant, Depression, Genetic Variation, Antipsychotic Drugs, Neurocognitive Deficits, Anxiety Disorders and Cognitive-Behavioral Therapy.
- Pharmacogenetics
- Testosterone
- Hormone Therapy
- Serotonin
- Dopamine
- Cognitive-Behavioral Therapy
- Neurocognitive Deficits
- Genetic Variation
- Antidepressant
- Metabolic Syndrome
- Depression
- Antipsychotic Drugs
- Anxiety Disorders
- Aldosterone
- Primary Aldosteronism
- Erectile Dysfunction
- Sexual Dysfunction
- Cytochrome P450
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Metabolic Syndrome223 topics
- Antidepressant201 topic
- Depression201 topic
- Genetic Variation122 topics
- Antipsychotic Drugs91 topic
- Neurocognitive Deficits91 topic
- Anxiety Disorders81 topic
- Cognitive-Behavioral Therapy81 topic
- Aldosterone71 topic
- Dopamine71 topic
- Primary Aldosteronism71 topic
- Serotonin71 topic
- Erectile Dysfunction61 topic
- Hormone Therapy61 topic
- Sexual Dysfunction61 topic
- Testosterone61 topic
- Cytochrome P45051 topic
- Pharmacogenetics51 topic
Where does Louis F. Fabre work?
Louis F. Fabre's main affiliation in the publication record is Texas Research Institute, United States.
How many publications and citations does Louis F. Fabre have?
OpenAlex counts 64 works and 2,150 citations for Louis F. Fabre, an h-index of 24, ranking #1,880,267 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Louis F. Fabre. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.